Hinge Health Inc. Class A Common Stock vs QUALCOMM, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while QUALCOMM, Inc. trades at $170.04 (market cap $188.86B). The key difference: QUALCOMM, Inc. is far larger — about 22.3× Hinge Health Inc. Class A Common Stock's market cap, and QUALCOMM, Inc. pays a 2.08% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and QUALCOMM, Inc. for 87 Days on average.
| HNGE | QCOM | |
|---|---|---|
Market Cap | $8.47B | $188.86B |
Volume | 1,624,526 | 12,280,716 |
Sector | Health | Technology |
52-Week High | $105.14 | $251.10 |
52-Week Low | $31.17 | $124.07 |
Typical Hold Time | 0 Days | 87 Days |
Enterprise Value | $8.09B | $195.82B |
Dividend Yield | — | 2.08% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Qualcomm trades at $176.96, up 1.45% today, with mixed technical signals showing bearish moving averages but oversold RSI readings. The company reported strong revenue of $44.28B in 2025 but net income declined to $5.54B, reflecting margin compression. Recent news highlights Qualcomm's strategic pivot toward AI and data center opportunities, including a potential $60B Amazon partnership that could diversify revenue streams beyond mobile chips.
Qualcomm presents a compelling risk-reward profile with analyst consensus target of $204.48 suggesting 15.5% upside. The company's expansion into AI/data center markets offers growth potential, but execution risks remain high as it navigates competition and the loss of Apple's modem business. Current valuation at 20.21 P/E appears reasonable if AI initiatives gain traction.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →